Latest Filgrastim Stories
Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,
RnRMarketResearch.com adds "Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2014" to its store.
THOUSAND OAKS, Calif., Dec. 2, 2010 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that it will present data from several key NplateÂ® (romiplostim) studies at the 52nd Annual Meeting and Exposition of the American Society of Hematology (ASH), Dec. 4-7, 2010, in Orlando, Fla.
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.